-
In an interview with IRB Advisor, Greg Koski talks about the initiatives launched and the success realized during his time as director of the Office for Human Research Protections.
-
Recently updated guidelines for human subjects biomedical research highlight the international research communitys concerns that studies conducted in poor nations may give too little attention to the health and well-being of participants who have few options and fewer medical resources.
-
The proposal for the study, A Multicenter, Randomized Dose Response Study of the Safety, Clinical and Immune Responses of DryVax Vaccine Administered to Children 2 to 5 Years of Age, provides the following details.
-
The continuing publicity surrounding both ever increasing public financial support for clinical research and claims of improper human research activities has led to calls for additional oversight of the clinical research enterprise.
-
The Council for International Organizations of Medical Sciences (CIOMS) published in October 2002 its revised and updated International Ethical Guidelines for Biomedical Research Involving Human Subjects. Here is a brief look at the new and revised guidelines.
-
A new federal advisory panel that will provide ethical guidance for researchers engaged in studies involving human subjects has been charged by the Bush administration to consider human embryos to be human subjects, deserving of the same protections currently afforded fetuses, children, and adults.
-
A list of all IRB Advisor articles published in 2002, organized by topic.
-
-
Boston Scientific (Natick, Massachusetts) rolled out preliminary results from its FIRE clinical trial, which studied the companys FilterWire EX Embolic Protection Device, during a symposium at last months American Heart Association meeting.
-
Apparently unique among the worlds vertebrates, the zebrafish can regenerate its heart. We think that zebrafishs most important future role will be in regeneration research, says the senior author of a report in the Dec. 13 issue of Science.
